RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

September 20, 2019

Study Completion Date

October 11, 2019

Conditions
Periodontitis
Interventions
DRUG

BMP-2

lyophilized Human Bone Morphogenetic Protein-2 was used as an active drug.

PROCEDURE

PRF

For the preparation of sticky bone, the patient's venous blood is collected and centrifuged at 2400rpm for 2min which leads to two different layers in the vacutainer the upper autologous fibrin glue (AFG) and the lower RBC portion, the upper AFG is mixed with a particulate bone graft (hydroxyapatite). Within 5-10 min fibrin meshwork was formed

Trial Locations (1)

509002

SVS Institute of Dental Sciences, Mahabubnagar, Hyderabad

All Listed Sponsors
lead

SVS Institute of Dental Sciences

OTHER

NCT04368650 - RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter